References
- Singh, K., et al., Mst1/2 kinases restrain transformation in a
novel transgenic model of Ras driven non-small cell lung cancer.Oncogene, 2019: p. 1-13.
- Raniszewska, A., et al., PD-L1 expression on lung cancer stem
cells in metastatic lymph nodes aspirates. Stem Cell Reviews and
Reports, 2019. 15 (2): p. 324-330.
- Lara-Guerra, H. and J.A. Roth, Gene therapy for lung cancer.Critical Reviews™ in Oncogenesis, 2016. 21 (1-2).
- Aktaş, O.N., et al., Role of natural killer cells in lung
cancer. Journal of cancer research and clinical oncology, 2018.144 (6): p. 997-1003.
- Degos, C., et al., Endometrial tumor microenvironment alters
human NK cell recruitment, and resident NK cell phenotype and
function. Frontiers in immunology, 2019. 10 : p. 877.
- Li, Y., et al., M860, a Monoclonal Antibody against Human
Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin
via Granzyme B Induction. Molecules, 2019. 24 (20): p. 3640.
- Barrett, C.S., A.C. Millena, and S.A. Khan, TGF-beta Effects on
Prostate Cancer Cell Migration and Invasion Require FosB. Prostate,
2017. 77 (1): p. 72-81.
- Caramori, G., et al., Molecular links between COPD and lung
cancer: new targets for drug discovery? Expert opinion on therapeutic
targets, 2019. 23 (6): p. 539-553.
- Chollat-Namy, M., et al., The pharmalogical reactivation of p53
function improves breast tumor cell lysis by granzyme B and NK cells
through induction of autophagy. Cell death & disease, 2019.10 (10): p. 1-20.
- Hassan, I.A., et al., Low production of granzyme B by Cytotoxic
T cells and Natural killer cells associated with the increased levels
of cytokines and chemokine’s in early diagnostic lung cancer
patients. International Journal of Cancer and Biomedical Research,
2020.
- Travis, W., et al., ES12. 05 Impact of STAS in Lung Cancer
Staging. Journal of Thoracic Oncology, 2019. 14 (10): p. S45.
- Seeligmüller, N., Faster Isolation of PBMC Using Ficoll-Paque.
Plus in the Eppendorf® Centrifuge 5920 R . 2016, Application Note.
- Adan, A., et al., Flow cytometry: basic principles and
applications. Critical reviews in biotechnology, 2017.37 (2): p. 163-176.
- Green, K.J., D.G. Rowbottom, and L.T. Mackinnon, Exercise and
T-lymphocyte function: a comparison of proliferation in PBMC and NK
cell-depleted PBMC culture. Journal of Applied Physiology, 2002.92 (6): p. 2390-2395.
- Datta, S.C. and M.R. Opp, Lipopolysaccharide-induced increases
in cytokines in discrete mouse brain regions are detectable using
Luminex xMAP® technology. Journal of neuroscience methods, 2008.175 (1): p. 119-124.
- Lin, X.-R., et al., CIK cell-based delivery of recombinant
adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the
anti-tumor effect and safety in lung cancer. Journal of cancer
research and clinical oncology, 2019. 145 (5): p. 1123-1132.
- Jiang, X., et al., Role of the tumor microenvironment in
PD-L1/PD-1-mediated tumor immune escape. Molecular cancer, 2019.18 (1): p. 1-17.
- Huang, J.Y., et al., Circulating markers of cellular immune
activation in prediagnostic blood sample and lung cancer risk in the
Lung Cancer Cohort Consortium (LC3). International journal of cancer,
2019.
- Giraldo, N.A., et al., The clinical role of the TME in solid
cancer. British journal of cancer, 2019. 120 (1): p. 45-53.
- Butler, S.J., et al., Prevalence of lung cancer in chronic
obstructive pulmonary disease: A systematic review. Respiratory
Medicine: X, 2019: p. 100003.
- Yan, C., et al., Antibiotics and immunotherapy in
gastrointestinal tumors: Friend or foe? World Journal of Clinical
Cases, 2019. 7 (11): p. 1253.
- Fu, Y., et al., LncRNA CASC11 promotes TGF-β1, increases cancer
cell stemness and predicts postoperative survival in small cell lung
cancer. Gene, 2019. 704 : p. 91-96.
- Diaz-Montero, C.M., et al., Increased circulating
myeloid-derived suppressor cells correlate with clinical cancer stage,
metastatic tumor burden, and doxorubicin–cyclophosphamide
chemotherapy. Cancer immunology, immunotherapy, 2009. 58 (1):
p. 49-59.
- Alghamri, M.S., et al., Functional assay to assess T-cell
inhibitory properties of myeloid derived suppressor cells (MDSCs)
isolated from the tumor microenvironment of murine glioma models , inMethods in Enzymology . 2020, Elsevier. p. 215-228.
- Cechova, K., et al., Up-regulation of mu-, delta- and
kappa-opioid receptors in concanavalin A-stimulated rat spleen
lymphocytes. J Neuroimmunol, 2018. 321 : p. 12-23.
- Turajlic, S., et al., Tracking cancer evolution reveals
constrained routes to metastases: TRACERx renal. Cell, 2018.173 (3): p. 581-594. e12.
- De, U., et al., Plumbagin from a tropical pitcher plant
(Nepenthes alata Blanco) induces apoptotic cell death via a
p53-dependent pathway in MCF-7 human breast cancer cells. Food and
chemical toxicology, 2019. 123 : p. 492-500.
- Shimojima, Y., et al., Characteristics of circulating natural
killer cells and their interferon-γ production in active adult-onset
Still disease. The Journal of rheumatology, 2019. 46 (10): p.
1268-1276.
- Wang, H., et al., Tumor-derived soluble MICs impair CD3+ CD56+
NKT-like cell cytotoxicity in cancer patients. Immunology letters,
2008. 120 (1-2): p. 65-71.
- Hu, Q., et al., Role of ALDH1A1 and HTRA2 expression in
CCL2/CCR2-mediated breast cancer cell growth and invasion. Biology
open, 2019. 8 (7): p. bio040873.
- Saad, M.I., et al., ADAM17 selectively activates the IL‐6
trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer. EMBO
molecular medicine, 2019. 11 (4).
- Donnenberg, A.D., J.D. Luketich, and V.S. Donnenberg, Secretome
of pleural effusions associated with non-small cell lung cancer
(NSCLC) and malignant mesothelioma: therapeutic implications.Oncotarget, 2019. 10 (60): p. 6456.